FT573: Preclinical Development of Multiplexed-Engineered Ipsc-Derived NK Cells Expressing a Novel Camelid Nanobody Chimeric Antigen Receptor (CAR) Targeting Pan-Cancer Antigen B7-H3
Cancer Research(2022)
AI Read Science
Must-Reading Tree
Example

Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined